Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01993914 · ClinicalTrials.gov registry record
Prevalence of MTHFR Polymorphisms in Venous Disease
A clinical trial of Thrombosis and Venous Disease, sponsored by Health Diagnostic Laboratory.
- Completed
- Registry status
- 90
- Enrollment target
- 1
- Study location
NCT01993914: Completed study of Thrombosis and Venous Disease, sponsored by Health Diagnostic Laboratory.
NCT01993914 is a study of Thrombosis and Venous Disease that has completed, run by Health Diagnostic Laboratory. The registered enrollment target is 90 participants, below the 467-participant average among 28 other Thrombosis trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01993914, a study of Thrombosis and Venous Disease, has completed, sponsored by Health Diagnostic Laboratory.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The etiologies of varicose veins and the progression to more serious forms of chronic venous disease and identification of appropriate diagnostic tests to better aid patient management by identifying individuals who may benefit from more aggressive treatment and/ or prophylactic measures.
Primary Outcome
Determine whether the prevalence of the MTHFR mutation differs between patient with varicose veins compared to controls and with or without superficial vein thrombosis.
Conditions Studied
Study Locations (1)
California
- The Elite Laser Vein Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2011-02 |
| Est. Completion | 2014-11 |
What the finished NCT01993914 record still lists
NCT01993914 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 467-participant average among 28 other Thrombosis trials with a reported enrollment target (81% lower).
The record links to 4 conditions, with Thrombosis appearing as the primary indexed condition, and to 0 interventions.
NCT01993914 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01993914 about?
NCT01993914 is a clinical study titled "Prevalence of MTHFR Polymorphisms in Venous Disease". The etiologies of varicose veins and the progression to more serious forms of chronic venous disease and identification of appropriate diagnostic tests to better aid patient management by identifying individuals who may benefit from more aggressive treatment and/ or prophylactic measures.
What is the current status of trial NCT01993914?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2011-02. Estimated completion is 2014-11.
What conditions does trial NCT01993914 study?
This clinical trial studies the following conditions: Thrombosis, Venous Disease, Varicose Veins, MTHFR.
Who is sponsoring clinical trial NCT01993914?
This trial is sponsored by Health Diagnostic Laboratory, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01993914 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thrombosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01993914's enrollment target sits among peer trials
90 14th of 28 higher than 15 of 28 other Thrombosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Thrombosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RECRUITING
-
Positron Emission Tomography (PET) Imaging of Thrombosis
RECRUITING · Phase 1
-
Pharmacogenomics of Warfarin in Hispanics and Latinos
RECRUITING
-
Neonatal Platelet Transfusion Threshold Trial
RECRUITING · NA
-
Vascular Lab Resource (VLR) Biorepository
RECRUITING
-
Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia